FOXO Transcription Factors as Potential Therapeutic Targets in Neuroblastoma

Codice QR

FOXO Transcription Factors as Potential Therapeutic Targets in Neuroblastoma

None

Salvato in:

Dettagli Bibliografici
Autori principali:	Ausserlechner, Michael J., Hagenbuchner, Judith, Fuchs, Stefan, Geiger, Kathrin, Obexer, Petra
Natura:	Elettronico Capitolo di libro
Lingua:	inglese
Pubblicazione:	IntechOpen 2012
Soggetti:	Health Sciences
Accesso online:	https://www.intechopen.com/chapters/27487
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

p16INK4A – Connecting Cell Cycle Control to Cell Death Regulation in Human Leukemia
di: Obexer, Petra, et al.
Pubblicazione: (2011)

Emerging frontiers in epigenetic-targeted therapeutics for pediatric neuroblastoma
di: Xiaokang Wang, et al.
Pubblicazione: (2025-07-01)

Therapeutic strategies targeting SREBP transcription factors: an update to 2024
di: Yongdan Wang, et al.
Pubblicazione: (2025-05-01)

Ablation of macrophage transcriptional factor FoxO1 protects against ischemia–reperfusion injury-induced acute kidney injury
di: Yao He, et al.
Pubblicazione: (2025-06-01)

THE TRANSCRIPTION FACTOR NF-KB AS A THERAPEUTIC TARGET IN THE TREATMENT OF MALIGNANT TUMORS
di: K. Umezawa, et al.
Pubblicazione: (2017-01-01)

Small Molecule Drugs and Targeted Therapies for Neuroblastoma
di: Xue, Chengyuan, et al.
Pubblicazione: (2012)

The transcription factor dFOXO controls the expression of insulin pathway genes and lipids content under heat stress in <i>Drosophila melanogaster</i>
di: M. A. Eremina, et al.
Pubblicazione: (2021-09-01)

Transcription Factor Targets as Treatment for Medulloblastoma
di: Shahi, Mehdi H., et al.
Pubblicazione: (2011)

Targeting Transcriptional Dysregulation in Huntington’s Disease: Description of Therapeutic Approaches
di: Basso, Manuela
Pubblicazione: (2012)

MicroRNA Target Signatures in Advanced Stage Neuroblastoma
di: Chu, Victoria R., et al.
Pubblicazione: (2012)

Recurrent Neuroblastoma
di: Lau, Loretta M.S., et al.
Pubblicazione: (2012)

Prognostic factors of neuroblastoma in limited-resource settings
di: Roberta Gomes Ribeiro Gonçalves Pinto, et al.
Pubblicazione: (2025-07-01)

Drosophila-based screening of herbal compounds targeting FOXO signaling pathway in type 2 diabetes mellitus
di: Mukarram Mudjahid, et al.
Pubblicazione: (2025-07-01)

Metallothionein: Potential therapeutic target for osteosarcoma
di: Salma Siddiqui, et al.
Pubblicazione: (2019-04-01)

Genetic Factors Influencing the Risk and Clinical Outcome of Neuroblastoma
di: Lau, Diana T., et al.
Pubblicazione: (2012)

The Cell Biology of Neuroblastoma
di: Denny, John B.
Pubblicazione: (2012)

Bioactive Sphingolipids in Neuroblastoma
di: Rahmaniyan, Mehrdad, et al.
Pubblicazione: (2012)

Neuroblastoma: morphological pattern, molecular genetic features, and prognostic factors
di: A. M. Stroganova, et al.
Pubblicazione: (2016-04-01)

Risk factors of neuroblastoma: a systematic review and meta-analysis
di: Felix M. Onyije, et al.
Pubblicazione: (2025-06-01)

Potential Therapeutic Molecular Targets for Nasopharyngeal Carcinoma
di: Chen, Shih-Shun
Pubblicazione: (2012)

Therapeutic potential of targeting LAG-3 in cancer
di: Diwakar Davar, et al.
Pubblicazione: (2025-07-01)

Neuroblastoma and Whole Genome Searches
di: Capasso, Mario
Pubblicazione: (2012)

The Different Faces of Angiogenesis in Neuroblastoma
di: Poliani, Pietro Luigi, et al.
Pubblicazione: (2012)

Association of FOXO3 gene polymorphisms with egg-laying intervals in pigeon
di: Qiaoqiao Peng, et al.
Pubblicazione: (2025-08-01)

Netrin-1 in cancer: Potential biomarker and therapeutic target?
di: Umut Kefeli, et al.
Pubblicazione: (2017-04-01)

Mitophagy: A Potential Therapeutic Target for Tuberculosis Immunotherapy
di: Gao S, et al.
Pubblicazione: (2025-07-01)

GLUT1 as a Potential Therapeutic Target in Glioblastoma
di: FNU Ruchika, et al.
Pubblicazione: (2025-05-01)

RETRACTED ARTICLE: Association of the polymorphisms in FOXO1 gene and diabetic nephropathy risk
di: Jianxia Ma, et al.
Pubblicazione: (2019-12-01)

Regulation of Myogenesis by MechanomiR-200c/FoxO3 Axis
di: Junaith S. Mohamed, et al.
Pubblicazione: (2025-06-01)

Alternative TrkA Splicing and Neuroblastoma
di: Farina, Antonietta R., et al.
Pubblicazione: (2012)

Molecular Chaperones as Prognostic Markers of Neuroblastoma
di: Liao, Yung-Feng, et al.
Pubblicazione: (2012)

Molecular genetic features of neuroblastoma in adolescent
di: N. A. Andreeva, et al.
Pubblicazione: (2024-06-01)

Engineering neuroblastoma models for clinical translation
di: Taiyu Song, et al.
Pubblicazione: (2025-01-01)

Repurposed Antipsychotics as Potential Anticancer Agents: Clozapine Efficacy and Dopaminergic Pathways in Neuroblastoma and Glioblastoma
di: Catarina Moura, et al.
Pubblicazione: (2025-07-01)

Unlocking the therapeutic potential of thymus-isolated regulatory T cells
di: Yueyuan Hu, et al.
Pubblicazione: (2025-06-01)

Exosome encapsulation of miR-205-5p suppresses neuroblastoma progression by targeting RUNX2
di: Qi Liu, et al.
Pubblicazione: (2025-06-01)

The SUMOylation Pathway as a Potential Therapeutic Target in Multiple Myeloma
di: Driscoll, James J.
Pubblicazione: (2012)

Ferroptosis determinants - potential therapeutic targets glioblastoma stem cells
di: V. E. Shevchenko, et al.
Pubblicazione: (2022-10-01)

Gut Microbiota in Primary Sarcopenia: Mechanisms and Potential Therapeutic Targets
di: Leshan Chen, et al.
Pubblicazione: (2025-05-01)

Anti-scarring drug discovery: potential targets and therapeutic opportunities
di: Meiling Feng, et al.
Pubblicazione: (2025-12-01)